-
Pfizer Covid vaccine provides partial protection against Omicron: Study
expresspharma
December 10, 2021
The yet-to-be peer-reviewed study, posted on the pre-print repository medRxiv recently, also found that considerable immunity is retained in people who were both vaccinated and previously ...
-
Pfizer and BioNTech Provide Update on Omicron Variant
AmericanPharmaceuticalReview
December 09, 2021
Pfizer Inc. and BioNTech SE announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from v
-
COVID Booster Cuts Death Rate by 90%, Israeli Study Finds
Drugs
December 09, 2021
Booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest.
-
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant
prnasia
December 08, 2021
Sino Biological, Inc. (http://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-COV-2 virus...
-
Gritstone bio and CEPI extend deal to develop Omicron vaccine candidate
Pharmaceutical-Technology
December 08, 2021
Gritstone bio and the Coalition for Epidemic Preparedness Innovations (CEPI) have expanded their agreement to develop a self-amplifying mRNA (SAM) vaccine against the Omicron variant of the SARS-CoV-2 virus.
-
Vaccine makers could make Omicron-specific booster, says Fauci
expresspharma
December 07, 2021
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony Fauci told reporters at a White House briefing.
-
Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose
expresspharma
December 07, 2021
The Parliamentary Standing Committee on Health, which presented its report recently, also said that concerns with regard to the new strain developing immunoescape mechanism should be critically addressed
-
GPs in England to defer services to accelerate booster jab delivery
PharmaTimes
December 07, 2021
GP practices can now postpone minor surgery and routine health checks for over-75s and new patients until 31 March 2022 to ensure booster jabs are rapidly and effectively delivered.
-
Rapid test identifies antibody effectiveness against COVID-19 variants
WorldPharmaNews
December 07, 2021
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person’s neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.
-
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations
prnasia
December 07, 2021
Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron...